improv cadav renal transplant outcom verapamil review cyclosporin csa substanti advanc organ transplant due immunosuppress properti use direct nephrotox effect initi studi mice csa dose-rel inhibit subcapsular microcircul subsequ clinic investig inhibitori effect effort csa-induc nephrotox calcium antagonist exampl calcium antagonist verapamil initi csa renal blood flow verapamil therapi reject episod week transplant csa therapi current studi mg renal arteri surgeri mg day regimen delay function incid need dialysi first post-transpl week kidney technic failur graft loss secondari patient verapamil benefici effect verapamil therapi transplant outcom abil cell ischemia select vasodil effer arteriol csa blood level inher immunosuppress properti 